Pharmacokinetic features
In terms of its physicochemical properties, atenolol is a hydrophilic substance. Its low lipophilicity directly determines several key pharmacokinetic parameters. First, the absorption of the drug from the gastrointestinal tract is incomplete. As a result, the oral bioavailability of atenolol is only about 50%.
Second, its hydrophilicity is the reason why the substance crosses the blood-brain barrier (BBB) extremely poorly. Consequently, unlike the lipophilic propranolol, atenolol has a minimal, negligible effect on the central nervous system (CNS). This makes it the preferred choice for patients prone to neurological adverse reactions.
Cardioselectivity and safety
One of the most important characteristics of atenolol is its relative, moderate cardioselectivity. The selectivity index of this drug is 14–35, which is considered low compared to more modern analogs.
The clinical significance of this fact is quite substantial: due to its moderate selectivity of action, atenolol retains the ability to cause adverse effects typically associated with non-selective beta-blockers. Of course, these undesirable events occur to a lesser extent than with truly non-selective drugs, but the physician must consider the risk of their development when prescribing therapy.
Indications, dosing, and duration of action
In clinical practice, the drug is prescribed for the following conditions:
- Arterial hypertension (to control blood pressure levels);
- Effort angina pectoris (as part of antianginal therapy);
- Arrhythmias (to stabilize heart rhythm).
The drug is administered either intravenously or orally. For oral administration, the standard dosing regimen involves taking the drug twice a day.
In terms of its duration of action, atenolol occupies an intermediate position among other beta-blockers: it acts longer than metoprolol, but its effect is shorter than that of nadolol. The half-life ($t_{1/2}$) is 6–7 hours. It is important to note, however, that after a single dose, the clinical therapeutic effect can persist for up to 24 hours.
Briefly: answers to topical questions
What specific side effects can atenolol cause?
Atenolol causes side effects common to β-blockers, as well as reactions typical of non-selective drugs due to its moderate cardioselectivity. Specific adverse effects include:
- Atrioventricular block — impairment of cardiac conduction.
- Decreased myocardial contractility — negative inotropic effect.
- Bradycardia — slowing of the heart rate.
- Bronchospasm — a consequence of the blockade of bronchial β2-receptors.
- Peripheral vascular spasm — a vascular reaction.
Central side effects (CNS effects) are significantly less pronounced than those of lipophilic analogs.
What are the absolute contraindications to the use of atenolol?
An absolute contraindication to the use of atenolol is pregnancy. The drug is strictly not recommended for pregnant women due to the high risk of congenital malformations and intrauterine fetal death. General contraindications to the drug are similar to those for propranolol, although their exact list is not detailed in the sources.
How is atenolol eliminated from the body?
Atenolol is excreted from the body predominantly by the kidneys in unchanged form in the urine. The drug has a high renal clearance, and only a small fraction is eliminated as metabolites.
| Characteristic | Description |
|---|---|
| Main pathway | Via kidneys (in urine) |
| Form of excretion | Predominantly unchanged |
| Dialyzability | Yes |
In renal failure and elderly patients, due to decreased glomerular filtration, the drug may accumulate, which requires mandatory dose adjustment.
Remember the profile of atenolol via the letter "M" (Moderate): Moderately absorbed (50%), Moderate selectivity (index 14-35), Moderate duration (between metoprolol and nadolol).
What else to study on this topic
- Pharmacokinetic features of lipophilic beta-blockers using propranolol as an example
- Comparative analysis of the duration of action of beta-blockers: nadolol, atenolol, metoprolol
- Side effects of non-selective beta-blockers and the clinical significance of the selectivity index
- The concept of intrinsic sympathomimetic and membrane-stabilizing activity of drugs
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Atenolol" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Drugs Acting on Adrenergic Synapses"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.